TABLE 3.
Results of univariate and multivariable analysis for DSS
| Univariate P value |
Multivariable adjusted HR (95% CI) |
P value | |
|---|---|---|---|
| Age >54 y | 0.94 | ||
| Sex | 0.05 | .929 | |
| Male | 1.06 (0.27-4.18) | ||
| Female | Ref | ||
| BMI >29.3 kg/m2 | 0.458 | ||
| Distant metastasis | 0.745 | ||
| Adjuvant chemotherapy | 0.862 | ||
| Preoperative chemotherapy | 0.803 | ||
| Maximum SUV >9.4 | 0.186 | ||
| MTV >47.5 mL | 0.623 | ||
| TLG >197 SUVlbm*mL | 0.346 | ||
| Type of operation | 0.186 | ||
| Distant resection | 0.105 | ||
| R status | 0.303 | ||
| TTR <12 mo | 0.059 | 2.77 (1-7.62) | .049 |
| NLR >3.7 | 0.119 | ||
| PLR >208.5 | 0.287 | ||
| LMR <4 | 0.023 | 4.18 (1.18-14.76) | .027 |
| MPV >10.7 | 0.595 | ||
| NAR <1.1 | 0.392 |
Abbreviations: BMI, body mass index, CI, confidence interval; DSS, disease-specific survival; HR, hazard ratio; LMR, lymphocyte-to-monocyte ratio; MPV, mean platelet volume; MTV, metabolic tumor volume; NAR, neutrophil-to-albumin ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; SUV, standardized uptake value; TLG, total lesion glycolysis; TTR, time to recurrence.